| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/29/2004 | US20040019211 Crystal structured fungicides selected from itraconazole, posaconazole or saperconazole used for prevention or prophylaxis of fungi, yeasts and dermatophyte infections |
| 01/29/2004 | US20040019184 Remedies for ischemic disease |
| 01/29/2004 | US20040019130 Aqueous solution mixture of polymer, calcium compound and phosphate; buffered pH |
| 01/29/2004 | US20040019129 Preparation of ophthalmic compositions |
| 01/29/2004 | US20040019122 Solid dispersion composition |
| 01/29/2004 | US20040019112 Treatment modality and method for fungal nail infection |
| 01/29/2004 | US20040019096 Matrix formulation containing an organic acid; hypotensive agents; congestive heart failure and angina treatments |
| 01/29/2004 | US20040019075 New formulation for the parenteral application of crobenetine |
| 01/29/2004 | US20040019074 Mixtures of fatty esters, lipophilic excipients and nonionic surfactants, used as solubilizers for drugs selected from rapamycin, tacrolimus, deoxyspergualin, mycophenolate-mofetil, nifedipine, nimodipine, etoposide or ibuprofen |
| 01/29/2004 | US20040019073 Mixtures of di-2-thienylglycolates, water, buffers, preservatives and stabilizer agents, administered for prophylaxis of respiratory system disorders such as asthma or chronic obstructive pulmonary disease |
| 01/29/2004 | US20040019072 Dimer-selective RXR modulators and methods for their use |
| 01/29/2004 | US20040019062 Parasiticidal formulation for animals |
| 01/29/2004 | US20040019028 Administering to a patient with mild cognitive impairment, a specific glucocorticoid receptor antagonist such as mifepristone to improve performance on a paragraph recall test |
| 01/29/2004 | US20040019014 Washing starch containing more than 85% amylopectin in order to remove surface-localized proteins, lipids and endotoxins, dissolving the starch in aqueous medium, molecular weight reduction by shearing |
| 01/29/2004 | US20040019012 A therapeutic drug suitable for topical administration to an eye, containing an antibiotic for gram-positive bacterial infection, a cyclodextrin compound to maintain drug in solution and cetylpyridium chloride |
| 01/29/2004 | US20040019011 Treatment of conitions and disease |
| 01/29/2004 | US20040019010 Carrageenan viscoelastics for ocular surgery |
| 01/29/2004 | US20040018996 Unit dosage forms for the treatment of herpes simplex |
| 01/29/2004 | US20040018992 Pharmaceutical compositions for sparingly soluble therapeutic agents |
| 01/29/2004 | US20040018989 Pulmonary delivery for levodopa |
| 01/29/2004 | US20040018962 Drug delivery vehicles |
| 01/29/2004 | US20040018958 Methods for therapy of radiation cutaneous syndrome |
| 01/29/2004 | US20040018956 Aporphine esters and their use in therapy |
| 01/29/2004 | US20040018327 Delayed release dosage forms |
| 01/29/2004 | US20040018259 Use of at least one extract of a plant of the genus lannea in a cosmetic or dermopharmaceutical composition |
| 01/29/2004 | US20040018252 Which destroy, inhibit or therapeutically significantly limit microbial growth within said preparations or medications |
| 01/29/2004 | US20040018251 Petasite extract is recovered from plant of the genus Petasites; effective in treating gastrointestinal diseases, asthmas, pollinosis, dysmenorrhea, eczemas, migraines, psoriasis and high blood pressure |
| 01/29/2004 | US20040018243 Modulation of release from dry powder formulations |
| 01/29/2004 | US20040018242 Nanoparticulate nystatin formulations |
| 01/29/2004 | US20040018241 Bioadhesive compositions and methods for topical administration of active agents |
| 01/29/2004 | US20040018240 Method for producing preparation containing bioactive substance |
| 01/29/2004 | US20040018239 Pharmaceutical preparation containing copolyvidone |
| 01/29/2004 | US20040018238 Biodegradable vehicles and delivery systems of biolgically active substances |
| 01/29/2004 | US20040018237 Topical drug delivery using phosphatidylcholine |
| 01/29/2004 | US20040018236 Encapsulating active drug with a solubilizer polymer EUDRAGIT", target releasing in gastrointestinal tracts, resistant to gastric juice and soluble in intestinal juices, drug delivery |
| 01/29/2004 | US20040018235 An anticholesterol agents comprising pitavastatin, for treating hypercholesterolemia; time-release agents |
| 01/29/2004 | US20040018234 Four different dosage forms, two antibiotics inhibiting protein and non-protein synthesis, one comprising immediate release and sustained release, the other three has sustained release forms, twenty-four hour period; bacterial infections |
| 01/29/2004 | US20040018233 An expectorant drug delivery dosage forms comprises a sustained release portion and an immediate release portion; relieving from bronchial mucus accumulation |
| 01/29/2004 | US20040018232 Drugs comprising titanium dioxide pigments, titanium dioxide and/or iron oxide coated on inorganic substrates; use as food color |
| 01/29/2004 | US20040018231 Mixing an emulsion of diacetylated monoglycerides, sodium lauryl sulfate, and colloidal silicon dioxide into gelatin solution, homogenizing, shaping, hardening |
| 01/29/2004 | US20040018230 Rehydrating a freeze dried liposome, encapsulating anesthetic bupivacaine, by agitating in water, washing the liposomes in hyperosmotic saline; storage stability, sustained release |
| 01/29/2004 | US20040018229 Insoluble drug delivery |
| 01/29/2004 | US20040018226 Electroprocessing of materials useful in drug delivery and cell encapsulation |
| 01/29/2004 | US20040018200 >/= 15 mg/ml of an antibody, or a fragment that immunospecifically binds to a respiratory syncytial virus antigen and histidine in an aqueous carrier |
| 01/29/2004 | US20040018190 Drugs and foods improving the quality of life and process for producing the same |
| 01/29/2004 | US20040018179 Bioadhesive directed somatic cell therapy |
| 01/29/2004 | US20040018157 Oral composition providing enhanced oral hygiene properties |
| 01/29/2004 | US20040018153 The invention relates to propellant gas formulations containing suspensions of the crystalline monohydrate of (1 7-((hydroxydi-2-thienylacetyl)oxy)-9, 9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.02,4)nonane-bromide. |
| 01/29/2004 | US20040018152 Biologically active molecules encapsulated in self-assembling, diketopiperazine microspheres, TECHNOSPHEREs tm ) and methods for making and administering such compositions are described herein. The compositions can be used to immunize individuals |
| 01/29/2004 | US20040017018 Flowing drugs, proteins, cells and/or microorganisms solutions or suspensions, from reservoirs into chemical reactors, where drops are generated and balls are formed by precipitating the drops, then coating and rinsing; encapsulation |
| 01/29/2004 | US20040016427 Method and apparatus for generating an aerosol |
| 01/29/2004 | DE19952982B4 Verfahren zur gerichteten Verpackung von molekularen Substanzen in Proteinhüllen Method for the directed packaging of molecular substances in protein shells |
| 01/29/2004 | DE10233108A1 Retardiertes Schmerzmittel enthaltend Tilidin und ein Lichtschutzmittel Retarded painkillers containing Tilidin and a light stabilizer |
| 01/29/2004 | DE10232113A1 Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel Vardenafil hydrochloride trihydrate containing medicines |
| 01/29/2004 | DE10232065A1 Behandlung von Zitzen oder Eutern von Säugetieren nach dem Melken mit barrierebildenden Schaumsystemen Treatment of teats or udders of mammals after milking with barrier-forming foam systems |
| 01/29/2004 | DE10224108A1 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol enthaltendes Arzneimiitel mit verzögerter Wirkstofffreisetzung 1-dimethylamino-3- (3-methoxy-phenyl) -2-methyl-pentan-3-ol-containing sustained release Arzneimiitel |
| 01/29/2004 | CA2498982A1 4-(4-methylpiperazin-1-ylmethyl)-n-[4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating anaplastic thyroid cancer |
| 01/29/2004 | CA2493674A1 Dendrimers as molecular translocators |
| 01/29/2004 | CA2492995A1 Nanoparticles for the administration of active ingredients, method of producing said particles and composition containing same |
| 01/29/2004 | CA2492878A1 Enhancing the effect of radioimmunotherapy in the treatment of tumors |
| 01/29/2004 | CA2492869A1 Method and apparatus for making miniature tablets |
| 01/29/2004 | CA2492862A1 Gastrointestinal delivery of genetic material coupled to a transporting agent |
| 01/29/2004 | CA2492806A1 Targeted agents for nerve regeneration |
| 01/28/2004 | EP1384474A1 Injectable composition containing taxol |
| 01/28/2004 | EP1384473A1 Stable gabapentin containing more than 20 ppm of chlorine ion |
| 01/28/2004 | EP1384472A1 Method for producing an organic solvent-free lycopene concentrate, the resulting concentrate and composition comprising said concentrate |
| 01/28/2004 | EP1384471A1 Osmotic extented-release dosage form |
| 01/28/2004 | EP1384403A1 Adjuvant for transcutaneous immunization |
| 01/28/2004 | EP1383816A1 Film-forming composition for topical use and use thereof for delivering active agents |
| 01/28/2004 | EP1383786A1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
| 01/28/2004 | EP1383782A1 Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication |
| 01/28/2004 | EP1383738A2 Alkyl and/or alkenyl glycerol carbamates |
| 01/28/2004 | EP1383735A1 Methods of synthesizing acylanilides including bicalutamide and derivatives thereof |
| 01/28/2004 | EP1383692A1 Packaging system for transdermal drug delivery systems |
| 01/28/2004 | EP1383594A1 Deagglomerator apparatus and method |
| 01/28/2004 | EP1383571A2 Microprojection array immunization patch and method |
| 01/28/2004 | EP1383556A1 Injection device for administering rna |
| 01/28/2004 | EP1383537A1 Novel chocolate composition as delivery system for nutrients and medications |
| 01/28/2004 | EP1383529A2 Methods of treating disorders of the eye and surrounding tissue with thymosin 4 (t 4), analogues, isoforms and other derivatives |
| 01/28/2004 | EP1383527A1 Methods and compositions for treating oral and esophageal lesions |
| 01/28/2004 | EP1383522A2 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of inflammatory skin conditions |
| 01/28/2004 | EP1383521A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue |
| 01/28/2004 | EP1383520A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa |
| 01/28/2004 | EP1383519A2 Treatment solution used for caring for wounds in addition to dressing material for use with said treatment solution |
| 01/28/2004 | EP1383516A1 Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer |
| 01/28/2004 | EP1383512A1 Use of sucralfate for the treatment of cervical erosion |
| 01/28/2004 | EP1383504A1 Sustained release drug delivery system containing codrugs |
| 01/28/2004 | EP1383502A2 Compounds and methods for the treatment of urogenital disorders |
| 01/28/2004 | EP1383486A2 Compositions containing cgmp pde inhibitors and local anestetic agents for nasal application |
| 01/28/2004 | EP1383485A1 Gastric juice-resistant device for releasing mucoadhesive active substance excipients and method for producing this gastric juice-resistant device |
| 01/28/2004 | EP1383484A1 Medicinal tablet with prolonged release of the active principle |
| 01/28/2004 | EP1383483A1 Controlled delivery of tetracycline compounds and tetracycline derivatives |
| 01/28/2004 | EP1383482A2 Method for manufacturing a low dose pharmaceutical composition |
| 01/28/2004 | EP1383481A1 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 01/28/2004 | EP1383480A2 Lipid-comprising drug delivery complexes and methods for their production |
| 01/28/2004 | EP1383479A2 Ph-sensitive mucoadhesive film-forming gels and wax-film composites |
| 01/28/2004 | EP1383464A1 Nail compositions and methods of administering same |
| 01/28/2004 | EP1383445A1 Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
| 01/28/2004 | EP1383399A1 Nutritional supplement to treat macular degeneration |
| 01/28/2004 | EP1383386A1 Improved anti-inflammatory herbal composition and method of use |